1 follower
Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class ant... Read more
Alex Martin
Elemental Enzymes
1 follower
Thermo Fisher Scientific
174 followers
Genentech
159 followers
Gilead Sciences
133 followers
Regeneron
101 followers
BioMarin Pharmaceutical
36 followers
10X Genomics
13 followers
VaxCare
1 follower
Spectrix Analytical Services
1 follower
Sage Therapeutics
5 followers
Foundation Medicine
5 followers
Explore companies